On Track: The FDA-
TRACK Monthly Newsletter
What’s New in April 2016
New performance data are available for the dashboards below.
Most Popular
- Most Popular Quarterly Content: Visit this page for the most viewed content in FY16 Q2.
Cross Agency
- Advisory Committees Dashboard: The FDA advisory committees vacancy rate is at 17% at the end of FY16 Q1.
Center for Devices and Radiological Health (CDRH)
- CDRH Dashboard: CDRH has accomplished its goal of assessing 100% device types subject to premarket approval (PMA) to determine whether or not to shift some premarket data requirements to the postmarket setting or to pursue down classification.
Center for Drug Evaluation and Research (CDER)
- CDER Dashboard: The number of orphan drugs addressing rare diseases approved in November 2015 was 8, the highest since CDER began tracking this measure in 2012.
Office of the Commissioner (OC)
- Office of Operations (OO) Dashboard: OO has realigned their dashboard to mirror the strategic priorities outlined in the OO 2015 – 2018 Strategic Plan. This new strategic plan balances delivery requirements with enhancing strategic partnerships with customers.
Office of Special Medical Programs (OSMP)
- OSMP Dashboard: The Office of Combination Products issued 100% of its formal Request for Designation (RFD) decisions and 91% of its informal requests decisions within 60 days in FY16 Q1.
No hay comentarios:
Publicar un comentario